Cochrane · systematic review · CD008720
Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation
Reavey, J, Vincent, K, Child, T, et al. · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library
Gynaecology and FertilityAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
3
No studies
1
Included studies
NR
No studies 1 · 25%Ungraded 0 · 0%Very low 0 · 0%Low 3 · 75%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Human chorionic gonadotrophin (hCG) priming for subfertile women undergoing in vitro maturation (IVM)
Population: Subfertile women undergoing in vitro maturation
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Live Birth Rate | OR 0.65 [0.24, 1.74] | 1 study · 82 participants | Low Downgraded: risk of bias, imprecision |
Miscarriage Rate | OR 0.6 [0.21, 1.72] | 2 studies · 282 participants | Low Downgraded: risk of bias, imprecision |
Clinical Pregnancy Rate | OR 0.52 [0.26, 1.03] | 2 studies · 282 participants | Low Downgraded: risk of bias, imprecision |
Adverse events and drug reactions | no estimate extracted | NR | No studies |